SETTING: A tuberculosis control project in Bangladesh. OBJECTIVE: To document the frequency and diagnostic value of smears with scanty acid-fast bacilli (AFB) (IUATLD/WHO scale, < 10/100 high power fields), and to assess the appropriateness of the current positivity threshold. DESIGN: Analysis of databases of laboratory registers, patient records and the diagnostic yield of sputum collection strategies. RESULTS: Scanty smears constituted about 10% of suspect and almost 50% of follow-up smears. In suspect series, 10% of scanty 1-9/100 were not confirmed by another positive or scanty AFB sputum, compared to 7.5% of results at the current cut-off value of 10/100. Considering such results as positive by adopting a lower cut-off as low as the 1/100 used in the ATS scale added 1.5% false positives at the most. In return, the gain in confirmed positive cases was up to 10%, and that in positive results exceeded the incremental yield of the third diagnostic sputum. Significance of scanty follow-up smears at the end of the intensive phase was suggested by their association with treatment failure and unfavourable outcome overall. CONCLUSIONS: Scanty results (IUATLD/WHO scale) are not rare and should not be ignored. Adoption of a considerably lower positivity threshold would be appropriate in control programmes where basic conditions for reliable AFB microscopy, including regular quality assessment, are present.
SETTING: A tuberculosis control project in Bangladesh. OBJECTIVE: To document the frequency and diagnostic value of smears with scanty acid-fast bacilli (AFB) (IUATLD/WHO scale, < 10/100 high power fields), and to assess the appropriateness of the current positivity threshold. DESIGN: Analysis of databases of laboratory registers, patient records and the diagnostic yield of sputum collection strategies. RESULTS: Scanty smears constituted about 10% of suspect and almost 50% of follow-up smears. In suspect series, 10% of scanty 1-9/100 were not confirmed by another positive or scanty AFB sputum, compared to 7.5% of results at the current cut-off value of 10/100. Considering such results as positive by adopting a lower cut-off as low as the 1/100 used in the ATS scale added 1.5% false positives at the most. In return, the gain in confirmed positive cases was up to 10%, and that in positive results exceeded the incremental yield of the third diagnostic sputum. Significance of scanty follow-up smears at the end of the intensive phase was suggested by their association with treatment failure and unfavourable outcome overall. CONCLUSIONS: Scanty results (IUATLD/WHO scale) are not rare and should not be ignored. Adoption of a considerably lower positivity threshold would be appropriate in control programmes where basic conditions for reliable AFB microscopy, including regular quality assessment, are present.
Authors: Mavinga D Phanzu; Aombe E Bafende; Bofunga B D Imposo; Wayne M Meyers; Françoise Portaels Journal: Am J Trop Med Hyg Date: 2010-03 Impact factor: 2.345
Authors: Anne-Marie Demers; Suzanne Verver; Andrew Boulle; Robin Warren; Paul van Helden; Marcel A Behr; David Coetzee Journal: BMC Infect Dis Date: 2012-09-14 Impact factor: 3.090
Authors: Maryline Bonnet; Laramie Gagnidze; Willie Githui; Philippe Jean Guérin; Laurence Bonte; Francis Varaine; Andrew Ramsay Journal: PLoS One Date: 2011-02-18 Impact factor: 3.240
Authors: David S Boyle; Ruth McNerney; Hwee Teng Low; Brandon Troy Leader; Ailyn C Pérez-Osorio; Jessica C Meyer; Denise M O'Sullivan; David G Brooks; Olaf Piepenburg; Matthew S Forrest Journal: PLoS One Date: 2014-08-13 Impact factor: 3.240
Authors: Saskia den Boon; Schalk W P van Lill; Martien W Borgdorff; Donald A Enarson; Suzanne Verver; Eric D Bateman; Elvis Irusen; Carl J Lombard; Neil W White; Christine de Villiers; Nulda Beyers Journal: Emerg Infect Dis Date: 2007-08 Impact factor: 6.883